RT
RECODE THERAPEUTICS, INC.
SEC filingBiotechnology · Menlo Park, CA
Amount raised$29.4Msold at filing
Total offering$29.4M
Investors in the raise26count reported to the SEC
FiledOct 23, 2025first sale Sep 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rana S. Al-HallaqDirector
Patricia S. MillicanDirector
Shehnaaz SulimanExecutive Officer, Director
Edward S. HurwitzDirector
Alan S. ColowickDirector
David S. LockhartExecutive Officer
Dean S. MitchellDirector
Basheer S. ZadaDirector
Inai S. ParkDirector
Helen S. KimDirector
Peter A. ThompsonDirector
Rakhshita S. DharDirector
Executive officers, directors and promoters as listed on the Form D.